12 February 2026
Growth: Quality volume and mix with market share gains in subdued market conditions ▪ Total volume declined 1.2%, with consolidated volume down 2.1%, and…
• Global comparable sales in the fourth quarter increased 5.7%, with positive global comparable guest counts and strong comparable sales growth across all segments…
2025 Full Year Results Sharper focus and disciplined execution driving competitive performance Full Year Key Highlights • Underlying sales growth (USG) 3.5%, with 1.5% volume growth; stronger…
11 February 2026
Strong execution and financial performance in 2025 Coca-Cola HBC AG, a growth-focused Consumer Packaged Goods business and strategic bottling partner of The Coca-Cola Company,…
HALF YEAR RESULTS FY2026 Renishaw, a world leader in measuring and manufacturing systems, today announces its interim results for the six months ended 31…
10 February 2026
Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period Revenue and EPS summary FY 2025 % Change Q4 2025 …
GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older GSK plc (LSE/NYSE: GSK) today announced that…
9 February 2026
Wynnstay Group plc (“Wynnstay” or “the Group” or “the Company”) Agricultural supplies and services group Final Results for the year ended 31 October 2025…